Complete remission after patisiran treatment in a patient with nephrotic syndrome secondary to hereditary transthyretin amyloidosis (ATTR)

被引：0
|
作者：
Vila, Axel [1 ]
Moktefi, Anissa [2 ,3 ]
Damy, Thibaud [4 ,5 ]
Plante-Bordeneuve, Violaine [6 ]
Remy, Philippe [1 ]
Colombat, Magali [7 ]
Audard, Vincent [1 ,2 ]
Sakhi, Hamza [1 ,2 ]
机构：
[1] Hop Univ Henri Mondor, Assistance Publ Hop Paris APHP, Ctr Reference Malad Rare Syndrome Nephrot Idiopath, Serv Nephrol & Transplantat, Creteil, France
[2] Univ Paris Est Creteil, Inst Mondor Rech Biomed IMRB, Inst Natl Sante & Rech Med, INSERM U955, Creteil, France
[3] Hop Univ Henri Mondor, Serv Anatomopathol, Creteil, France
[4] Univ Paris Est Creteil, Equipe CEpiA Clin Epidemiol & Aging, INSERM U955, IMRB, Creteil, France
[5] Hop Univ Henri Mondor, AP HP, Serv Cardiol, GRC Amyloid Res Inst,Ctr Reference Natl Amyloses C, Creteil, France
[6] Hop Univ Henri Mondor, AP HP, GRC Amyloid Res Inst, Serv Neurol, Creteil, France
[7] Ctr Hosp Univ Toulouse, Serv Anatomopathol, Toulouse, France
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2025年
关键词：
Hereditary Transthyretin Amyloidosis; Nephrotic Syndrome; Patisiran; Tafamidis;
D O I：
10.1080/13506129.2025.2472819
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Splenic regression of amyloid on multi-modality imaging in response to treatment with patisiran and diflunisal in hereditary transthyretin amyloidosis
    Patel, Rishi K.
    Fontana, Marianna
    Hawkins, Philip N.
    Gillmore, Julian
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (04): : 269 - 270
  • [32] Impact of baseline neuropathy stage in patients with hereditary transthyretin-mediated (hATTR) amyloidosis with or without patisiran treatment
    Kyriakides, T.
    Brannagan, T.
    Lin, H.
    Wang, Y.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 190 - 190
  • [33] Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis
    Matthias Schmidt
    Sebastian Wiese
    Volkan Adak
    Jonas Engler
    Shubhangi Agarwal
    Günter Fritz
    Per Westermark
    Martin Zacharias
    Marcus Fändrich
    Nature Communications, 10
  • [34] Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis
    Schmidt, Matthias
    Wiese, Sebastian
    Adak, Volkan
    Engler, Jonas
    Agarwal, Shubhangi
    Fritz, Guenter
    Westermark, Per
    Zacharias, Martin
    Faendrich, Marcus
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [35] Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy"
    Lin, Hollis
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Polydefkis, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (12) : 1529 - 1530
  • [36] REMISSION OF NEPHROTIC SYNDROME RELATED TO AA AMYLOIDOSIS AFTER HEPATIC ADENOMECTOMY
    MELIN, JP
    LECRIQUE, T
    WYNCKEL, A
    WONG, T
    NOEL, LH
    BELGHITI, J
    CHANARD, J
    NEPHRON, 1993, 64 (01): : 157 - 158
  • [37] Severe nephrotic syndrome in a patient with Schonlein-Henoch purpura: Complete remission after cyclosporin A
    Schmaldienst, S
    Winkler, S
    Breiteneder, S
    Horl, WH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (04) : 790 - 792
  • [38] A Patient with IgA Nephropathy: 5 Years after Complete Remission of Minimal Change Nephrotic Syndrome
    Kim, Ji Won
    Park, Jun Hyung
    Kim, Da Hee
    Kim, Hyung Young
    Kim, Sang Hyun
    Park, Won Do
    EWHA MEDICAL JOURNAL, 2016, 39 (04): : 118 - 121
  • [39] Complete remission of nephrotic syndrome in a woman with renal amyloidosis due to familial mediterranean fever
    Heras, Manuel
    Saiz, Ana
    Jose Fernandez-Reyes, Maria
    Molina, Alvaro
    Astrid Rodriguez, Maria
    Callejasa, Ramiro
    NEFROLOGIA, 2016, 36 (03): : 331 - 332
  • [40] Regression of Cardiac Bone-Tracer Uptake in Patients with Hereditary Transthyretin Amyloidosis after One Year Treatment with Patisiran. An early Marker of Treatment Response?
    Tingen, H.
    Tubben, A.
    Bijzet, J.
    van der Meer, P.
    van den Berg, M. P.
    Houwerzijl, E. J.
    van der Zwaag, P. A.
    Hazenberg, B. P. C.
    Slart, R. H. J.
    Nienhuis, H. L. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S220 - S221
12345